Skip to main content

Table 1 Characteristics of studies involved in radiotherapy of PT treatment

From: Adjuvant radiotherapy and chemotherapy for patients with breast phyllodes tumors: a systematic review and meta-analysis

Author

Year

Countr

Follow-up

No. case

Radio

Surgery Type(%)

Age

Tumor size (cm)

Histological Type(%)

Margin(%)

LR

DFS

OS

MS

BCS

M

Be

Bo

Ma

<  1 cm (positive)

➢ 1 cm (negative)

Barth

2009

Lebano

56 m

46

46

100

0

49 (mean)

3.7(mean)

/

34.8

63.2

34.8

63.2

0

46

44

2

Belkacemi

2008

France

106 m

443

39

85.1

14.9

40 (median)

3(median)

64.1

18.1

17.8

15

43

4

26

34

/

Chaney

1998

USA

36.5 m

8

8

12.5

87.5

43 (median)

10.4(median

12.5

25

62.5

25

75

0

8

8

/

Chaney

2000

USA

47 m

101

6

47

53

41 (median)

4

58.4

11.8

30

(0.1)

(99.9)

0

6

5

/

Chen, W

2005

Taiwan

71 m

172

2

6.4

93.6

37 (mean)

5.8(mean)

76.1

6.9

17

(7.5)

(92.5)

0

/

2

2

Cheng

2006

Taiwan

30 m

81

2

72.8

27.2

37(mean)

7.7

72.8

7.4

19.8

(6.2)

(93.8)

0

/

2

0

Choi

2018

Korea

5 yrs

362

31

73.2

26.8

43(median)

6(mean)

/

64.9

35.1

(10.4)

(89.6)

1

30

31

0

Cohn-Ce

1991

Sweden

8 yr

77

24

40.2

59.8

50(median)

NA

51.9

0

48.1

/

/

13

/

/

3

Demian

2016

Egypt

52 m

35

4

57

43

40(median)

6.8

3

37

60

(20)

(80)

0

4

4

0

Gnerlic

2014

USA

53 m

3120

446

56

44

51.1(mean)

4.2(median)

/

/

100

(10)

(90)

132

/

/

/

Guillot

2011

France

12.65 m

165

8

58.7

41.3

44(median)

3

65.5

21.8

12.7

27.8

71.2

2

/

6

/

Joshi,

2003

India

35 m

26

4

46.2

53.8

38(median)

6(mean)

65.4

11.5

23.1

(15.4)

(84.6)

0

4

/

0

Liew, K. W.

2018

Sabah

11 m

11

6

36

64

45(median)

10.5(median)

0

0

100

(27)

(73)

4

2

6

0

Mitus

2019

Poland

12 yrs

340

12

100

0

51(mean)

6(mean)

/

33

67

100

0

0

12

12

0

Park, H. J.

2019

Korea

76 m

43

43

61.4

37.6

42(median)

5.8(median)

0

0

100

(9)

(91)

0

37

37

6

Stranzl

2004

Austri

33.8 m

6

6

/

100

53(median)

7(median)

/

33

67

67

33

/

4

5

0

Varghese

2017

India

20 m

92

9

51.1

48.9

43(median)

10(median)

60

23

17

/

/

1

8

9

0

  1. BCS breast conserving surgery, M mastectomy, Be benign, Bo borderline, Ma malignant, LR local recurrence, DFS disease-free survival, OS overall survival MS metastasis